Molecular mechanisms underlying human synovial sarcoma development. - Test2 - elhamkhani - TriplyDB

Molecular mechanisms underlying human synovial sarcoma development.

Molecular mechanisms underlying human synovial sarcoma development.

http://www.wikidata.org/entity/Q33927348

about

The cancer-related protein SSX2 interacts with the human homologue of a Ras-like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IP Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma Synovial sarcoma of the abdominal wall: Imaging findings and review of the literature Fusions of the SYT and SSX genes in synovial sarcoma.Conserved SNH domain of the proto-oncoprotein SYT interacts with components of the human chromatin remodelling complexes, while the QPGY repeat domain forms homo-oligomers Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas The SSX gene family: characterization of 9 complete genes Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma SYT-SSX1 (synovial sarcoma translocated) regulates PIASy ligase activity to cause overexpression of NCOA3 protein Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1.Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells.Clinical impact of molecular and cytogenetic findings in synovial sarcoma.The SSX family of cancer-testis antigens as target proteins for tumor therapy.Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2.Identification of PDZK4, a novel human gene with PDZ domains, that is upregulated in synovial sarcomas.Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma.Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cells.Synovial sarcoma: from genetics to genetic-based animal modeling [Results of treatment of synovial sarcoma of the limbs].Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis.Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.Recurrent pulmonary synovial sarcoma effectively treated with amrubicin: A case report Molecular target therapy for synovial sarcoma.Reduced risk of synovial sarcoma in females: X-chromosome inactivation?A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitro Diagnostic Approach to Synovial Sarcoma of the Head and Neck Illustrated by Two Cases Arising in the Face and Oral Cavity.The First Ever Reported Case of Primary Synovial Sarcoma of Scalp.The clinical implication of SS18-SSX fusion gene in synovial sarcoma.Diagnostic and prognostic sarcoma signatures.Outcome and the effect of age and socioeconomic status in 1318 patients with synovial sarcoma in the English National Cancer Registry: 1985-2009.Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.Synovial sarcoma of the spine: A report of three cases and review of the literature.Molecular diagnosis of soft tissue neoplasia: clinical applications and recent advances.Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases.Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction.Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer.Synovial sarcoma cell lines showed reduced DNA repair activity and sensitivity to a PARP inhibitor.

P2860

Q24297259-EF81475D-1552-4D98-8A56-0761E3ADBA35 Q24307530-5870D3B3-6018-4368-87DA-B1DD795D920E Q24673690-1E6F80B5-4307-46A1-BB89-2C59E0DA1ADE Q26863656-2415AC12-2523-4820-9818-37C420624243 Q27824775-56BF43B8-9C50-49D6-8804-1B432F00DCDA Q28182275-683A725A-ED8E-4A06-A409-2653B9B4DCB4 Q28201703-CAE033AB-5ADA-45C3-BBFE-B6A7428D3B20 Q28221334-193C3E46-D6E3-4375-A6DF-3FABADA4E7AE Q28271454-6642D757-568A-42A5-939A-A10939A00B02 Q28568099-325C90BD-EC8B-44DA-94CB-D1AB7321C0CE Q30914150-9BF53262-CFC0-4E04-B6CA-F1D61CC8A153 Q33615450-A8107F93-1E6C-46DD-BBC2-C96BB0D7B890 Q34082692-9FD5458D-2C94-4158-9251-D22F25E323E1 Q34146229-92274641-8CAE-46AA-9C1E-94175E125295 Q34272305-3472FDAD-E33E-4F68-A863-F37BCEA33DA8 Q34312526-24E18B7C-1F22-4A58-83FB-6526299E3543 Q34580595-4F963087-5A0D-47A9-A875-E1DFB3387D0C Q34587139-61BCF392-A970-4811-B5D3-C78442322A32 Q34593303-14DD9042-E556-4A8D-994B-D2F21C2D8D61 Q34808827-9FBB3A01-748A-4D79-B063-5F6ED6647C00 Q35018901-1F31C1B5-6ADF-4785-A19E-BE3362AF3857 Q35733359-700863F5-4D2D-4303-8B65-3C6A76974B43 Q35747809-2D4DBF84-DE10-4BAF-BAC0-D9874121BDFA Q35754124-61195B59-E58F-4786-9C60-97EF51638BA4 Q36429636-F31B4E05-6709-4418-B3CE-FEC86290274E Q36624241-377FFE9C-F631-426B-9E99-24311A4E11BF Q36716591-68DB29EF-05F1-48BD-86A5-AABB4CD2E64F Q36850467-9E43AD88-34DB-4D0B-8F84-4CBCDFB16BA9 Q36906350-2DEF941F-422A-4F5F-B300-8E8CDDEC7357 Q37089234-6F9520B2-423A-44EA-ACBE-A30E50B3F1A8 Q37235515-B99E7165-4790-4EE0-B4E9-25439C12E8AE Q37335373-37EEF2DA-3040-4361-987D-CB2477582638 Q37350221-176ED99D-B5F2-415A-B402-0C2B16FB0F4E Q37737327-E7FA0E05-9081-492E-AFCF-CA7B38791C69 Q37851837-EF7FBCCB-BF3B-430C-AC6B-C51DCAC5B726 Q38238574-922E6C06-0F1B-4D10-B9FB-DEFFAF012D5D Q38456787-FE596271-FAE9-40B3-A60D-E12D253838C0 Q38457922-2A676357-8113-4C48-8050-2F7FD7665326 Q38567366-CA4967FA-A6DF-4142-94EC-A07769BA23CC Q38761160-5995C712-6D38-4B73-9BC6-E2D42ADA3F89

P2860

Molecular mechanisms underlying human synovial sarcoma development.

http://www.wikidata.org/entity/Q33927348

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Molecular mechanisms underlying human synovial sarcoma development.

@ast

Molecular mechanisms underlying human synovial sarcoma development.

@en

type

label

Molecular mechanisms underlying human synovial sarcoma development.

@ast

Molecular mechanisms underlying human synovial sarcoma development.

@en

prefLabel

Molecular mechanisms underlying human synovial sarcoma development.

@ast

Molecular mechanisms underlying human synovial sarcoma development.

@en

P1433

Q33927348-7861D994-5E82-42F5-8949-AFA997945247

P1476

Q33927348-38EA153F-96C5-4510-8EF7-C4489243834D

P2093

Q33927348-6A359CFF-B53E-461F-8716-AC470B489B41

Q33927348-8BB6DE49-F2BF-4B7E-A193-5694286AD404

Q33927348-DAF5562A-7D4D-4992-9598-059F3D90DB52

P2860

Q33927348-003131C5-1BA0-4431-A107-08BA4ED6FAAD

Q33927348-136A9682-B667-4BE5-A3CE-8DD08C708673

Q33927348-13B030A3-FBE4-48D1-90BC-CD15792B35B8

Q33927348-14C2152F-A635-47C5-B730-CB8AFF5BFCEC

Q33927348-17E62ED6-07E8-4EC3-A027-5996736ECB94

Q33927348-18C57EBC-49B6-4B83-BB56-4AFDBFD323AB

Q33927348-1BBC7884-1B50-425D-9BFC-B555905512FC

Q33927348-205A8AEB-88A1-4670-A61E-599BB3B95D7E

Q33927348-23359A91-B527-4341-816D-7565E53D9E53

Q33927348-24D6769F-3AEE-4F9F-A2A4-F37D202E4517

P304

Q33927348-0241A612-8CEA-4582-AE84-5F3194623D7C

P31

Q33927348-73D6771F-B212-46F4-B4FC-CF1956BFABD3

P356

Q33927348-D91E379D-B568-4677-92A9-8F9331D4D16C

P433

Q33927348-F3285C94-34ED-4043-BE40-36B706A90186

P478

Q33927348-E910F6D3-4E42-49D2-960F-17D00718BC7C

P577

Q33927348-373C60A8-3458-4835-BE61-805ECD024B6B

P698

Q33927348-4F1DD310-9684-483D-96FB-7023C3D09CC3

P356

1098-2264(2000)9999:9999%3C::AID-GCC1056%3E3.0.CO;2-G

P1433

Genes, Chromosomes and Cancer

P1476

Molecular mechanisms underlying human synovial sarcoma development.

@en

P2093

de Bruijn DR

http://www.w3.org/2001/XMLSchema#string

dos Santos NR

http://www.w3.org/2001/XMLSchema#string

van Kessel AG

http://www.w3.org/2001/XMLSchema#string

P2860

Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

Calcium-dependent binding of sorcin to the N-terminal domain of synexin (annexin VII)

Krüppel-associated boxes are potent transcriptional repression domains

A novel fusion gene, SYT-SSX4, in synovial sarcoma.

SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.

Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins

Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins

The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies

P304

1-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11107170

http://www.w3.org/2001/XMLSchema#string